Media & Analysis
3 Q&A interviews with MVA-membersContact person
3 Q&A Interview with John Sommer, Nordic Managing Director, MVA-member, DPR Construction
1) Why does DPR Construction find the Medicon Valley region particularly interesting? Medicon Valley is very interesting because it is the largest life sciences hub in Europe and growing about 8-10 % year on year. This is a region where more and more global clients are establishing their...
3 Q&A interview with Henrik Schlieker, Business Development Executive, MVA-member PCI Pharma Services Germany GmbH
1) Why have PCI decided to join Medicon Valley Alliance? As an industry leading global CDMO, PCI Pharma Services have been active in the Nordic region for a number of years. Having developed many relationships and partnerships in the region’s life science, pharma and biotech industry, joining MVA...
3 Q&A interview with Jonas Söderström, CEO MVA-member, BioStock
1) Why has Biostock decided to join Medicon Valley Alliance? Being the number one investor-targeted media channel with a strict focus on the life sciences and health sector, as well as being based smack in the middle of the Medicon Valley uptake area, it feels very natural to us to join this...
3 Q&A Interview with, Karen Brosbøl Wulf, Senior Business Director in the municipality of Gladsaxe – The nr. 1 life science municipality in Medicon Valley
“In Gladsaxe municipality, we create sustainable business development, both on the environmental, economic and social bottom line” Karen Brosbøl Wulf, Senior Business Director Q1: In terms of number of employees in the life science industry, the municipality of Gladsaxe is the leading life science...
3 Q&A Interview Alexandra Pichard Nielsen, Vice President Business Development, MVA-member, Porton Pharmasolutions Denmark
1) As a company with a global presence, what is specifically interesting about this region? This region consists of life science companies in a variety of sizes and with different clinical focus, and all these companies are very important contributors to the global drug development efforts. No...
3 Q&A Interview with James Gubbins, partner, MVA-member, Covington
1) As a global law firm specialising in life science, what do you consider particularly interesting or challenging in the Medicon Valley region and in the Nordics? The Nordics, and especially the Medicon Valley, present an exciting opportunity for cooperation for a firm like Covington. We recently...
3 Q&A Interview with Ivana, Group CEO, OptimaPharm
Q1: Why has Optimapharm chosen to join Medicon Valley Alliance? A: Growing in the Nordics is just one of our development plans which is why having the well-established nordic Crown CRO join the Optimapharm family was so important. As Crown and Optimapharm had been strong partners for over 10...
3 Q&A with Christian Roghi, Director, Microbiome Solutions, Eagle Genomics
What is Eagle Genomics’ elevator pitch? Eagle Genomics is a software business that is pioneering the application of network science to biology across the Food and Nutrition, Beauty and Personal Care, AgBio and Healthcare sectors. Its purpose is to accelerate the generative economy through the...
3 Q&A Interview with Viktoriya Vasilenko, CEO of Knowledge Gate Group
Q1: Who is Knowledge Gate Group and what makes your concept unique? A1: Knowledge Gate Group is a tech company that is building a platform-based solution that identifies and connects life science experts to companies. This allows critically important life-saving research to be accelerated as...
3 Q&A Interview with Dr. Peter Hölig, Head of Business Development, and Dr. Sarah Frühwirth, Product Manager for Scandinavia, from our new MVA-member company, Lipoid
Q1: What is Lipoid's core expertise? Lipoid was founded in 1977 by Dr. Herbert Rebmann with the objective to develop and produce pharmaceutical grade phospholipids. As the global market leader, Lipoid supplies them at industrial scale and supports drug and vaccine product development projects from...